Search
-
Norway patient organisation funding disclosure 2022
Media
https://www.gsk.com/media/10110/norway-patient-organisation-funding-disclosure-2022.pdf
First published: 10 May 2023
-
Norway patient organisation disclosure 2022
Media
https://www.gsk.com/media/10097/norway-patient-organisation-disclosure-2022.pdf
First published: 13 June 2023
-
Dapro_26June
Media
https://www.gsk.com/media/10340/press-release-gsk-receives-positive-chmp-op.pdf
First published: 26 June 2023
-
Press Release Japan Accepts Arexvy Regulatory Application To Prevent RSV Disease In Adults Aged 50 59
Media
https://www.gsk.com/media/10736/press-release-japan-accepts-arexvy-regulatory-application-to-prevent-rsv-disease-in-adults-aged-50-59.pdf
First published: 12 December 2023
-
Press Release Japan File Acceptance Arexvy 50 59
Media
https://www.gsk.com/media/10737/press-release_japan-file-acceptance-arexvy-50-59.pdf
First published: 12 December 2023
-
Meet The Respiratory Management Slides
Media
https://www.gsk.com/media/8184/meet-the-respiratory-management-slides.pdf
First published: 06 June 2022
-
Responsible Business Supplement 2016
Media
https://www.gsk.com/media/8102/responsible-business-supplement-2016.pdf
First published: 01 June 2022
-
Glaxosmithkline Euro Medium Term Note Programme Prospectus Document 2014
Media
https://www.gsk.com/media/7913/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2014.pdf
First published: 31 May 2022
-
Glaxosmithkline Euro Medium Term Note Programme – Prospectus Document 2014
Media
https://www.gsk.com/media/8536/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2014.pdf
First published: 10 June 2022
-
Emma Walmsley Key Priorities
Media
https://www.gsk.com/media/8161/emma-walmsley-key-priorities.pdf
First published: 06 June 2022